MEI Pharma, Inc.·4

Jun 6, 4:37 PM ET

Urso David M 4

4 · MEI Pharma, Inc. · Filed Jun 6, 2023

Insider Transaction Report

Form 4
Period: 2023-06-02
Urso David M
Sr. V.P. and General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-02+166,571166,571 total
    Exercise: $7.50Exp: 2033-06-02Common Stock (166,571 underlying)
Footnotes (1)
  • [F1]One quarter of such options shall vest on June 2, 2024, and the remaining three quarters of such options shall vest monthly over a three year period beginning on June 2, 2024.

Documents

1 file
  • 4
    form4.xmlPrimary